Skip to main content
Premium Trial:

Request an Annual Quote

Neuroscience Microarray Consortium Installs Affy and Illumina Array Tools at Yale, TGen

NEW YORK (GenomeWeb News) — A National Institutes of Health-led group of research facilities has installed Illumina and Affymetrix array tools to support collaborative neuroscience whole genome association studies, the group said Wednesday.
 
The group, Neuroscience Microarray Consortium, has centers at the University of California, Los Angeles, Duke University, Yale University, and is based out of the Translational Genomics Research Institute Phoenix, Ariz.
 
“[T]hese high-throughput genotyping services will ultimately make a dramatic impact in clinical care of neurological disorders,” NMC chairman and TGen neurogenomics director Dietrich Stephan said in a statement.
 
Stephan told GenomeWeb Daily News that the NMC is working with roughly $25 million in NIH funding. He said the group bought an Illumina BeadLab 1,000 in late 2006, and that the system is “up and running” at Yale, and that TGen’s lab in Phoenix is running an Affy Human Mapping 500K Array Set.
 
As many as 10,000 researchers will have access to the hardware for whole-genome studies, particularly researchers studying genes linked to neurological disorders.
 
The consortium member institutions each offer different services, the NMC said: TGen offers expression profiling and SNP-genotyping using Affy’s Gene Chips; Yale offers genotyping using both Affy and Illumina services; UCLA uses the Affy platform; and Duke contributes LCM services.
 
Yale scientist Shirkant Mane said the addition of the Illumina platform “will significantly aid the research goals of the neuroscientist.”
 
Additional information about the NMC can be found here.

The Scan

Tens of Millions Saved

The Associated Press writes that vaccines against COVID-19 saved an estimated 20 million lives in their first year.

Supersized Bacterium

NPR reports that researchers have found and characterized a bacterium that is visible to the naked eye.

Also Subvariants

Moderna says its bivalent SARS-CoV-2 vaccine leads to a strong immune response against Omicron subvariants, the Wall Street Journal reports.

Science Papers Present Gene-Edited Mouse Models of Liver Cancer, Hürthle Cell Carcinoma Analysis

In Science this week: a collection of mouse models of primary liver cancer, and more.